NSC |
Compound |
Enrichment |
Correlation |
NSC 678925 |
1-Phenazinecarboxamide, N-[2-(dimethylamino)ethyl]- 9-fluoro-, monohydrochloride |
0.0422011701988039 |
0.32397025 |
NSC 681239 |
Bortezomib |
0.0422011701988039 |
-0.071105986 |
NSC 681645 |
Camptothecin Derivative |
0.0422011701988039 |
0.062897638 |
NSC 691845 |
Null |
0.0422011701988039 |
0.23533692 |
NSC 701373 |
3-Pyridinecarbonitrile, 6-[4-[(7-chloro-4-quinolinyl)amino]phenyl]-1,2-dihydro- 4-(4-methoxy-1-naphthalenyl)-2-oxo- |
0.0422011701988039 |
0.054553044 |
NSC 701378 |
3-Pyridinecarbonitrile, 4-(4-chlorophenyl)- 6-[4-[[7-(trifluoromethyl)-4-quinolinyl]amino]phenyl]- 1,2-dihydro-2-oxo- |
0.0422011701988039 |
0.17277216 |
NSC 706739 |
Benzo[c]pyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione, 2-(dimethylamino)-5-ethyl- 3b,4,5,6,7,7a,12,12b-octahydro-9-methyl- |
0.0422011701988039 |
0.3433026 |
NSC 708445 |
3-Iodoacetamido-benzoic acid ethyl ester |
0.0422011701988039 |
0.35342396 |
NSC 710340 |
6H,7H-[1]Benzopyrano[4,3-b][1]benzopyran-7-one,3,8,10-tri hydroxy-9,11-bis(3-methyl-2-butenyl)-6-(2-methyl-1-propenyl)- (9CI) |
0.0422011701988039 |
0.14434152 |
NSC 713197 |
Benzo[g]quinoxaline-2,3-dicarboxylic acid, 5,10-dihydro-5,10-dioxo-, diethyl ester |
0.0422011701988039 |
0.031446029 |